Hem 712c digital blood pressure monitor

HRAs were completed at baseline, 8 and 32 weeks, using face-to-face computer assisted personal interviews, in English or Spanish based on the preference of the participant. Interviews were conducted by non-intervention staff who were community members and who received training in interviewing techniques. Height (inches) was recorded at baseline. Weight (pounds), waist circumference (cm), and three measures of resting systolic and diastolic blood pressure (micrograms mercury) were recorded (one minute between measurements, using an Omron HEM-712C digital blood pressure monitor) at each data collection point. At each data collection point, a fasting blood sample was collected using a finger stick to monitor total and high density lipids (mg/dL), and glucose (mg/dL) using a Cholestec LDX machine. Participants wore an Omron JH 112 pieso-electric pedometer for one week prior to initiating the walking groups to record baseline steps (T1, Figure 2), and for the duration of the study period.

Health Risk Assessments (HRAs) were completed at baseline, 8 and 32 weeks, using face-to-face computer assisted personal interviews, in English or Spanish based on the participant’s preference. HRAs included psychometric indicators, self-reported health and medication use, height (inches), weight (pounds), waist circumference (cm), three measures of resting systolic and diastolic blood pressure (micrograms mercury) (recorded using an Omron HEM-712C digital blood pressure monitor), and a fasting finger-stick blood sample to monitor total and high density lipids (mg/dL) and glucose (mg/dL) using a Cholestec LDX machine. Participants wore an Omron JH 112 pieso-electric pedometer for one week prior to initiating the walking groups to record baseline steps, and for the duration of the study period.